Whose territory is PKI going for here, QGENF's?
>>BEVERLY, Mass.--(BW HealthWire)--Dec. 19, 2001--Agencourt Bioscience Corporation, a provider of genomic services and products such as DNA Sequencing, SNP Genotyping and DNA Purification to the life sciences industry, today announced that it has signed a three-year distribution agreement with PerkinElmer Life Sciences, a leading provider of drug discovery, life science research and genetic disease screening solutions. Under terms of the agreement, PerkinElmer will use its worldwide sales network to distribute Agencourt's MCPrep(TM), AMPure(TM) and CleanSEQ(TM) nucleic acid purification kits for use on its Packard DNATrak(TM), as well as other robotic sample preparation and liquid handling systems.
Each purification kit consists of the patented Solid Phase Reversible Immobilization (SPRI(TM)) technology developed by Agencourt and used at the Whitehead Institute Center for Genome Research to purify more than 10 billion base pairs of DNA for the Human Genome Project. The MCPrep(TM) Plasmid purification kit is designed for the isolation of high-quality plasmid DNA for any molecular biology application and can process one plate every four to six minutes. The AMPure(TM) PCR purification kit can be used to purify amplicons as small as 100 bp, producing a yield of 90 percent or greater; the purified products can be used in a variety of applications, including microarray, sequencing and primer walking. CleanSEQ(TM) is a dye-terminator removal kit that binds sequencing products while washing away excess dyes, primers and salts; the purified products can be used for any sequencing application.
``This distribution agreement is a natural progression of the co-marketing arrangement announced last year,'' said John J. Engel, president of PerkinElmer Life Sciences. ``It demonstrates our continued commitment to offer effective solutions that work with our DNATrak and other automated sample preparation and liquid handling systems to empower functional genomics and molecular biology applications.''
The DNATrak is a robotic liquid handling system designed for high throughput automation of DNA purification and sequencing reaction setup and assembly. When coupled with Agencourt's SPRI chemistry, the system is capable of running more than 4,000 purification nucleic acid preparations per hour, a magnitude of nearly 10 times current industry average. The DNATrak automated microplate processors and DNATrak automated sample preparation systems are currently being used in conjunction with Agencourt's SPRI technology at numerous key genome centers throughout the United States.
``We are excited to have PerkinElmer Life Sciences as a strategic partner and distributor of our purification product line,'' said Brian McKernan, president and CEO of Agencourt. ``PerkinElmer's significant marketing and distribution strength in the life sciences market, coupled with their full line of liquid handling automation equipment, will provide Agencourt with immediate market presence and customer service capabilities. It will help us streamline the drug discovery pipeline of our customers.''<<
snip
Cheers, Tuck |
